Ade, LLC Bristol Myers Squibb CO Transaction History

Ade, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $130,320 - $151,923	-2,430 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $10,058 - $11,782	-170 Reduced 6.54%	2,430 $144,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $12,382 - $13,484	200 Added 8.33%	2,600 $174,000
Q1 2021 Apr 16, 2021	SELL	$59.34 - $66.74 $13,351 - $15,016	-225 Reduced 8.57%	2,400 $152,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $151,567 - $171,753	2,625 New	2,625 $163,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ade, LLC, based on Form 13F filings with the SEC.

Stay updated on Ade, LLC with notifications on news.